Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Ziopharm Oncology (ZIOP) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 37 quarters since 2012. Compare with ZIOP stock chart to see long term trends.

ZIOP stock compared to

ZIOP Income Statement

Revenue, Net:null
Research & Development Expense:13570000
Total Operating Expenses:22639000
Operating Income:-22639000
Net Income:-22670000
Earnings Per Share, Basic:-0.11
Shares Outstanding, Basic Avg:215559148

ZIOP Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-21452000
Net Cash from Financing Activities:19000
Property, Plant & Equipment Purchases:1877000
Net Cash from Investing Activities:-1877000
Net Change in Cash & Equivalents:-23310000

ZIOP Balance Sheet

Cash and Cash Equivalents:76746000
Total Current Assets:89407000
Property, Plant & Equipment, Net:11606000
Total Assets:106765000
Accounts Payable:982000
Total Short-Term Liabilities:13593000
Total Liabilities:18484000

Insider Trading

Change
Value
Transaction
SEC Form 4
Huang James   Director
100,000 sh at $2
$171,000
Buy
Weis Holger   Director
50,000 sh at $2
$91,500
Buy
Hagen Heidi   Director
23,770 sh at $2
$41,835
Buy
Postma Robert W   Director
20,508 sh at $2
$35,479
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
16,392,190 sh
-2,285,015 sh
-12%
$43,277
-$23,962
Vanguard Group Inc
15,777,466 sh
-269,988 sh
-2%
$41,652
-$16,119
Msd Partners, L.P.
15,151,516 sh
 
$40,000
Discovery Capital Management, LLC / Ct
12,487,227 sh
437,220 sh
4%
$32,966
-$10,414
State Street Corp
10,859,732 sh
-1,341,616 sh
-11%
$28,670
-$15,255
Miller Value Partners, LLC
10,317,698 sh
-1,516,969 sh
-13%
$27,238
-$15,367
JPMorgan Chase & Co
4,834,536 sh
-427,850 sh
-8%
$12,763
-$6,182
Geode Capital Management, LLC
3,551,709 sh
16,648 sh
0%
$9,376
-$3,350
Northern Trust Corp
2,296,437 sh
-75,979 sh
-3%
$6,064
-$2,478
Charles Schwab Investment Management Inc
1,478,785 sh
10,020 sh
1%
$3,904
-$1,384
Nuveen Asset Management, LLC
1,222,760 sh
348,828 sh
40%
$3,228
$81
Morgan Stanley
1,046,336 sh
122,136 sh
13%
$2,763
-$564
Morgan Stanley
1,046,336 sh
122,136 sh
13%
$2,763
-$564
Two Sigma Advisers, Lp
969,792 sh
6,600 sh
1%
$2,560
-$907
Citigroup Inc
958,913 sh
115,714 sh
14%
$2,532
-$504
Renaissance Technologies LLC
940,200 sh
503,600 sh
115%
$2,482
$910
Susquehanna International Group, Llp
860,008 sh
501,108 sh
140%
$2,270
$978
Two Sigma Investments, Lp
824,835 sh
-145,645 sh
-15%
$2,178
-$1,316
D. E. Shaw & Co., Inc.
689,615 sh
-292,614 sh
-30%
$1,821
-$1,715
Bank Of New York Mellon Corp
640,438 sh
-356,196 sh
-36%
$1,691
-$1,897

Data imported from Ziopharm Oncology Inc SEC filings. Check original filings before making any investment decision.